Global Pharmaceuticals & Biotech Leverage Leaders

Generate Biomedicines

Market Cap: US$2.1b

Generate Biomedicines, Inc., engaged in the field of generative biology by using machine learning for drug discovery and development through the programming of novel protein therapeutics in the United States.

Tango Therapeutics

Market Cap: US$4.4b

A precision oncology company, focuses on the discovery and development of drugs in defined patient populations with unmet medical need.

Immunome

Market Cap: US$2.2b

A biotechnology company, engages in the discovery, design, development, manufacturing, and commercialization of antibody-drug conjugates and other oncology therapeutics in the United States.

Celldex Therapeutics

Market Cap: US$2.8b

A biopharmaceutical company, engages in developing therapeutic antibodies for patients with severe inflammatory, allergic, autoimmune, and other diseases.

Summit Therapeutics

Market Cap: US$11.0b

A biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies.

Aspen Pharmacare Holdings

Market Cap: R68.8b

Manufactures and markets specialty and branded pharmaceutical products in Africa, the Middle East, the Americas, Europe CIS, Australasia, and Asia.

Roivant Sciences

Market Cap: US$24.5b

A clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines and technologies.

Ligand Pharmaceuticals

Market Cap: US$5.9b

A biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide.

BioArctic

Market Cap: SEK 27.9b

Develops biological drugs for patients with central nervous system disorders in Sweden.

ABIVAX Société Anonyme

Market Cap: €6.7b

A clinical-stage biotechnology company, develops therapeutics that harness the body’s natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases.

Vericel

Market Cap: US$2.2b

A commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies and specialty biologic products for sports medicine and severe burn care markets in North America.

Sichuan Kelun Pharmaceutical

Market Cap: CN¥56.6b

Researches, develops, produces, and sells infusion and non-infusion pharmaceutical products in China and internationally.

Viking Therapeutics

Market Cap: US$4.3b

A clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders.

Vertex Pharmaceuticals

Market Cap: US$121.9b

Operates as a biotechnology company in the United States, Europe, and internationally.

Krystal Biotech

Market Cap: US$10.6b

A commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States.

Shijiazhuang Yiling Pharmaceutical

Market Cap: CN¥24.5b

Shijiazhuang Yiling Pharmaceutical Co., Ltd.

MBX Biosciences

Market Cap: US$2.4b

A clinical-stage biopharmaceutical company, focuses on the discovery and development of precision peptide therapies for the treatment of endocrine and metabolic disorders.

Oruka Therapeutics

Market Cap: US$5.2b

A clinical-stage biopharmaceutical company, focuses on developing novel monoclonal antibody therapeutics for psoriasis (PsO), and other inflammatory and immunology (I&I) indications.

Almirall

Market Cap: €2.4b

Operates as a skin health-focused biopharmaceutical company in Spain, Europe, the Middle East, the United States, Asia, and Africa.

Beijing Tiantan Biological Products

Market Cap: CN¥22.6b

Beijing Tiantan Biological Products Co., Ltd.

Humanwell Healthcare (Group)Ltd

Market Cap: CN¥26.7b

Researches, develops, produces, and sells pharmaceutical products in China and internationally.

Samsung BiologicsLtd

Market Cap: ₩62.2t

Together with its subsidiaries engages in the manufacturing, commercializing, distributing, and selling of biopharmaceuticals products in South Korea, Europe, the United States, and internationally.

WuXi Biologics (Cayman)

Market Cap: HK$135.8b

An investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People’s Republic of China, North America, Europe, Singapore, Japan, South Korea, Australia, and Brazil.

Guangdong Zhongsheng Pharmaceutical

Market Cap: CN¥19.2b

Guangdong Zhongsheng Pharmaceutical Co., Ltd.

Hubei Jumpcan Pharmaceutical

Market Cap: CN¥23.4b

Engages in the research, development, production, and sale of drugs in China.

Dong-E-E-Jiao

Market Cap: CN¥27.9b

Engages in the research, development, production, and sale of donkey-hide gelatin and related products in China and internationally.

Caregen

Market Cap: ₩3.2t

A biotechnology company, researches, develops, and commercializes biomimetic peptides worldwide.

J. B. Chemicals & Pharmaceuticals

Market Cap: ₹360.2b

Manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (API) in India and internationally.

Lupin

Market Cap: ₹1.1t

Operates as a pharmaceutical company in India, the United States, and internationally.

Neuland Laboratories

Market Cap: ₹230.1b

Engages in the manufacture and sale of active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally.

Pharvaris

Market Cap: US$2.3b

A late-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases with unmet needs covering angioedema and other bradykinin-mediated diseases.

Veracyte

Market Cap: US$4.7b

Operates as a diagnostics company in the United States and internationally.

West Pharmaceutical Services

Market Cap: US$24.5b

Designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.

BioMarin Pharmaceutical

Market Cap: US$11.1b

A biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.

Relay Therapeutics

Market Cap: US$3.9b

Operates as a clinical-stage precision medicines company.

China Resources Jiangzhong PharmaceuticalLtd

Market Cap: CN¥14.1b

Engages in the manufacture of pharmaceutical products in China.